Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Appendicitis. --- Escherichia coli Infections.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Escherichia coli --- Escherichia coli --- Escherichia coli infections --- Colibacillose --- Escherichia coli --- Escherichia coli --- Congresses --- Congresses --- Congresses --- Congrès --- Congrès --- Congrès

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Shiga toxin-producing Escherichia coli (STEC) is an important foodborne pathogen associated with both outbreaks and sporadic cases of human disease, ranging from uncomplicated diarrhoea to haemorrhagic colitis (HC) and haemolytic uraemic syndrome (HUS). STEC affects children, elderly and immuno-compromised patients. STEC is capable of producing Shiga toxin type 1 (Stx1), type 2 (Stx2) or both, encoded by stx1 and stx2 genes, respectively. These strains are likely to produce putative accessory virulence factors such as intimin (encoded by eae), an enterohaemolysin (EhxA) and an autoagglutinating protein commonly associated with eae-negative strains (Saa), both encoded by an enterohaemorrhagic plasmid. Several studies have confirmed that cattle are the principal reservoir of STEC (O157 and non-O157:H7 serotypes) and many of these serotypes have been involved in HUS and HC outbreaks in other countries. Transmission of STEC to humans occurs through the consumption of undercooked meat, vegetables and water contaminated by faeces of carriers and by person-to-person contact. Diagnostic methods have evolved to avoid selective diagnostics, currently using molecular techniques for typing and subtyping of strains. Control is still a challenge, although there are animal vaccines directed against the serotype O157:H7.

Escherichia coli. --- E. coli (Bacterium) --- Escherichia --- environment --- Cattle --- STEC --- Virulence Factors --- Food

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Bacteria --- DNA, Bacterial --- Bacterial genetics --- Escherichia coli --- Génétique bactérienne --- genetics --- Genetics --- Génétique --- Génétique bactérienne --- Génétique --- DNA, Bacterial. --- genetics. --- Escherichia coli - Genetics --- Bacteria - genetics --- Escherichia coli - genetics --- Genes, bacterial

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

With the advent of recombinant DNA technology, expressing heterologous proteins in microorganisms rapidly became the method of choice for their production at laboratory and industrial scale. Bacteria, yeasts and other hosts can be grown to high biomass levels efficiently and inexpensively. Obtaining high yields of recombinant proteins from this material was only feasible thanks to constant research on microbial genetics and physiology that led to novel strains, plasmids and cultivation strategies. Despite the spectacular expansion of the field, there is still much room for progress. Improving the levels of expression and the solubility of a recombinant protein can be quite challenging. Accumulation of the product in the cell can lead to stress responses which affect cell growth. Buildup of insoluble and biologically inactive aggregates (inclusion bodies) lowers the yield of production. This is particularly true for obtaining membrane proteins or high-molecular weight and multi-domain proteins. Also, obtaining eukaryotic proteins in a prokaryotic background (for example, plant or animal proteins in bacteria) results in a product that lack post-translational modifications, often required for functionality. Changing to a eukaryotic host (yeasts or filamentous fungi) may not be a proper solution since the pattern of sugar modifications is different than in higher eukaryotes. Still, many advances in the last couple of decades have provided to researchers a wide variety of strategies to maximize the production of their recombinant protein of choice. Everything starts with the careful selection of the host. Be it bacteria or yeast, a broad list of strains is available for overcoming codon use bias, incorrect disulfide bond formation, protein toxicity and lack of post-translational modifications. Also, a huge catalog of plasmids allows choosing for different fusion partners for improving solubility, protein secretion, chaperone co-expression, antibiotic resistance and promoter strength. Next, controlling culture conditions like temperature, inducer and media composition can bolster recombinant protein production. With this Research Topic, we aim to provide an encyclopedic account of the existing approaches to the expression of recombinant proteins in microorganisms, highlight recent discoveries and analyze the future prospects of this exciting and ever-growing field.

Environmental sciences. --- Inclusion Bodies --- Escherichia coli --- Filamentous fungi --- Microalgae --- Recombinant Proteins --- Microorganism --- fusion tags --- yeast